The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2024

Filed:

Nov. 21, 2018
Applicant:

Modernatx, Inc., Cambridge, MA (US);

Inventors:

Raj Rajendran, Sharon, MA (US);

Patrick Finn, Franklin, MA (US);

Paolo G. V. Martini, Boston, MA (US);

Ding An, Waban, MA (US);

Athanasios Dousis, Boston, MA (US);

Kanchana Ravichandran, Cambridge, MA (US);

Assignee:

ModernaTX, Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 3/00 (2006.01); A61K 9/00 (2006.01); A61K 9/51 (2006.01); A61K 48/00 (2006.01); C12N 9/02 (2006.01);
U.S. Cl.
CPC ...
C12N 9/0071 (2013.01); A61K 9/0019 (2013.01); A61K 9/5123 (2013.01); A61K 48/0075 (2013.01); A61P 3/00 (2018.01); C12Y 114/16001 (2013.01);
Abstract

This disclosure relates to mRNA therapy for the treatment of hyperphenylalaninemias such as phenylketonuria (PKU). mRNAs for use in the invention, when administered in vivo, encode human phenylalanine hydroxylase (PAH), functional fragments thereof (e.g., those comprising the catalytic domain or the catalytic domain and the tetramerization domains), and fusion proteins comprising PAH. mRNAs of the invention are preferably encapsulated in lipid nanoparticles (LNPs) to effect efficient delivery to cells and/or tissues in subjects, when administered thereto. mRNA therapies of the invention increase and/or restore deficient levels of PAH expression and/or activity in subjects. mRNA therapies of the invention further decrease abnormal accumulation of phenylalanine associated with deficient PAH activity in subjects.


Find Patent Forward Citations

Loading…